[Increase of neopterin after treatment with granulocyte-macrophage colony-stimulating factor (GM-CSF)].
Melichar
B
B
Solichova
D
D
Jebavy
L
L
D000293:Adolescent; D000328:Adult; D000368:Aged; D000741:Anemia, Aplastic / Q000188:drug therapy / Q000652:urine*; D001708:Biopterins / Q000031:analogs & derivatives* / Q000652:urine; D005260:Female; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000494:pharmacology / Q000627:therapeutic use*; D006689:Hodgkin Disease / Q000188:drug therapy / Q000652:urine*; D006801:Humans; D008264:Macrophages / Q000187:drug effects; D008297:Male; D008875:Middle Aged; D009190:Myelodysplastic Syndromes / Q000188:drug therapy / Q000652:urine*; D019798:Neopterin; D013268:Stimulation, Chemical
D001708:Biopterins; D019798:Neopterin; D016178:Granulocyte-Macrophage Colony-Stimulating Factor
Elévation de la néoptérine après traitement par le facteur stimulant des colonies granulo-macrophagiques (GM-CSF).